Skip to content

Blackstone Ascent Posterior Occipital Cervico-Thoracic (POCT) System

by Blackstone Medical, Inc.

510(k) K080394

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK080394 Date13 Mar 2008ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KWP
Device Class
Class II
Regulation
21 CFR Part 888.3050
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Blackstone Ascent Posterior Occipital Cervico-Thoracic (POCT) System is a spinal fixation device designed for posterior occipital to cervico-thoracic junction fusion. It is classified as an orthopedic implant intended to stabilize the occiput through the cervical spine and into the upper thoracic region (occiput-T3).

This system is supplied sterile and intended for single-use, with FDA 510(k) clearance under Special Review (K080394). It is intended for surgical use in the orthopedic setting and requires proper handling and storage as a sterile medical device. The device is not MRI-safe and must be used in accordance with manufacturer instructions for optimal clinical outcomes.

Other devices from Blackstone Medical, Inc.

See all devices from Blackstone Medical, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific spinal regions does the Blackstone Ascent POCT System stabilize, and why is this design important for certain patients?

    The Blackstone Ascent POCT System is designed to stabilize the occiput (skull base) through the cervical spine and into the upper thoracic region, specifically up to the T3 vertebra. This extended fixation is particularly important for patients requiring occipito-cervico-thoracic fusion, such as those with severe instability, trauma, or degenerative conditions affecting this complex junction. The system’s design ensures stability across multiple segments to promote proper spinal alignment and fusion.

  • Is this device intended for reuse, or is it meant to be used only once? How should it be stored to maintain sterility?

    The Blackstone Ascent POCT System is explicitly intended for single-use only, as stated in its packaging and instructions. Since it is supplied sterile, proper storage in a clean, dry environment—protected from moisture, dust, and extreme temperatures—is critical to preserve sterility until use. Always follow the manufacturer’s storage guidelines to ensure the device remains uncontaminated.

  • Can this device be used in an MRI setting, or are there any safety concerns related to imaging?

    No, the Blackstone Ascent POCT System is not MRI-safe. This means it should never be used in patients who require MRI imaging, as the metallic components could cause artifacts or pose a risk during the procedure. Always verify imaging plans preoperatively and consult the manufacturer’s instructions for full safety details.

  • What types of surgical settings or procedures is this device approved for, and what kind of training is typically required?

    The device is approved for orthopedic surgical use in settings where spinal fusion procedures are performed, such as hospitals with neurosurgery or spine surgery departments. While the FDA has cleared it under Special Review (K080394), its use requires familiarity with posterior occipital-cervico-thoracic fixation techniques. Surgeons should have experience with similar spinal stabilization systems and adhere strictly to the manufacturer’s instructions for proper implantation.